Calls Purchased on Celldex Therapeutics (CLDX)

Shares of Celldex Therapeutics CLDX are higher on the session by 9.86%, currently trading at $3.79. The stock has been moving largely lower over the past six months and is currently trading below the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short while ago the February $4.00 call was purchased ~3,000 times, on the offer, on open interest of 2,047 contracts. Overall call volume is now running at 18.62x the daily average with 92% of all calls traded being purchases on the offer. Celldex Therapeutics, Inc. is a biopharmaceutical company, which applies its Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases.